Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition
Vanna Sanna, Sandro Satta, Tzung K. Hsiai, Mario Sechi
Topics & Concepts
NanocarriersChemistryCoronavirusAntiviral drugTargeted drug deliveryDrugViral entrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)AvidityVirologyVero cellDrug deliveryPharmacologyCoronavirus disease 2019 (COVID-19)VirusInfectious disease (medical specialty)MedicineImmunologyViral replicationDiseaseAntigenPathologyOrganic chemistrySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing